FDA permits marketing of first test for most common cause
FDA permits marketing of first test for most common cause of gastroenteritis outbreaks
The Ridascreen Norovirus 3rd Generation EIA assay is for use when a number of people have simultaneously contracted gastroenteritis and there is a clear avenue for virus transmission, such as a shared location or food.